GNTLF 财务： Genetic Technologies Limited AI 分析

主页

股票

GNTLF

财务数据

GNTLF 财务

Genetic Technologies Limited

收盘价：Mar 24, 16:00:00 GMT-4

盘前：Mar 25, 05:51:37 GMT-4

概述预测收益股息财务数据

关键数据

前收盘价

开盘价

当日区间

$1 - $1

52周范围

$1 - $1

交易量

100

平均成交量

股息收益率

每股收益（TTM）

-0.06

市值

$145.4M

什么是 GENETIC TECHNOLOGIES？

Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. The company is headquartered in Melbourne, Victoria and currently employs 58 full-time employees. The firm is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The firm has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The firm's segments include EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment relates to EasyDNA branded test sales and expenses. The AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType/Corporate: relates to geneType branded test sales and expense, includes corporate charges.

功能特性

资源

市场

收入

资产负债表

现金流量

年度

季度性

GNTLF 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	06/30/2024	06/30/2023	06/30/2022	06/30/2021	06/30/2020
营收	3	7	8	6	0	0
营收同比增长 (YoY)	-63%	-13%	33%	--	--	--
营收成本	2	3	4	3	0	0
毛利润	1	3	4	3	0	0
销售、一般及管理费用	7	11	10	12	5	4
研发	--	0	1	0	1	0
营业费用	8	14	14	11	7	6
其他非经营性收入 (费用)	0	0	0	0	0	--
税前利润	-8	-12	-11	-7	-7	-6
所得税费用	0	0	0	0	0	0
净利润	-9	-12	-11	-7	-7	-6
净利润增长	-25%	9%	56.99%	0%	17%	0%
稀释后流通股数	144.4	138.36	106.09	96.48	89.41	4,155.01
股份同比变动 (YoY)	20%	30%	10%	8%	-98%	47%
每股收益 (摊薄)	-0.05	-0.08	-0.11	-0.07	-0.07	0
每股收益增长率	-47%	-22%	50%	-7%	5,180%	-35%
自由现金流	-5	-9	-9	-5	-7	-5
每股自由现金流	--	--	--	--	--	--
毛利率	33.33%	42.85%	50%	50%	0%	0%
营业利润率	-200%	-142.85%	-125%	-116.66%	0%	0%
净利率	-300%	-171.42%	-137.5%	-116.66%	0%	0%
自由现金流利润率	-166.66%	-128.57%	-112.5%	-83.33%	0%	0%
EBITDA	-6	-10	-10	-7	-7	-6
EBITDA 利润率	-200%	-142.85%	-125%	-116.66%	0%	0%
EBITDA 中的折旧与摊销	0	0	0	0	0	0
EBIT	-6	-10	-10	-7	-7	-6
EBIT 利润率	-200%	-142.85%	-125%	-116.66%	0%	0%
有效税率	0%	0%	0%	0%	0%	0%

Follow-Up Questions

Genetic Technologies Limited 的关键财务报表是什么？



根据最新的财务报表（Form-10K），Genetic Technologies Limited 的总资产为 $6，净损失为 $-12

GNTLF 的关键财务比率是什么？



Genetic Technologies Limited 的流动比率是 1.5，净利 margin 为 -171.42，每股销售为 $0.05。

Genetic Technologies Limited 的收入按细分市场或地理位置如何划分？



Genetic Technologies Limited 最大收入来源是 Banking and Related Activities，在最近的收益报告中收入为 39,313,000。就地区而言， United States 是 Genetic Technologies Limited 的主要市场，收入为 39,313,000。

Genetic Technologies Limited 是否盈利？



不，根据最新的财务报表，Genetic Technologies Limited 的净损失为 $-12

Genetic Technologies Limited 有负债吗？



是的，Genetic Technologies Limited 的负债为 4

Genetic Technologies Limited 的流通股有多少？



Genetic Technologies Limited 的总流通股为 138.36

Genetic Technologies Limited (GNTLF) 财务

GNTLF 股价走势图